- Contreras A, Beems M, Tatar A, Sen S, Srinand S, Srinand P, Suresh M, Luther T, Cho C. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model. Journal for ImmunoTherapy of Cancer (2018) 6:41
- Contreras A, Sen S, Tatar AJ, Mahvi DA, Meyers JV, Srinand R, Suresh M, Cho CS. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice. Cancer Immunology, Immunotherapy, 65(5): 601-11, 2016 May. doi: 10.1007/s00262-016-1823-8. PMID: 27011014
- Mahvi DA, Meyers JV, Tatar AJ, Contreras A, Suresh M, Leverson GE, Sen S, Cho CS. Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice. Journal of Immunotherapy, 38(2):54-61, 2015 Feb-Mar. doi: 10.1097/CJI.0000000000000064. PMID: 25658614
- Cho H, Cho CS, Indig GL, Lavasanifar A, Vakili MR, Kwon GS. Polymeric micelles for apoptosis-targeting of cancer and intraoperative surgical guidance. PLoS One, 9(2):e89968, 2014 Feb. doi: 10.1371/journal.pone.0089968. PMID: 24587157
- Cho CS. Choosing a good basic science or translational research mentor. In: Kibbe M (Ed.) Success in Academic Surgery: Basic Science, London: Springer-Verlag 2014.
- Wentworth L, Meyers JV, Alam S, Russ AJ, Suresh M, Cho CS. Memory T cells are uniquely resistant to melanoma-induced suppression. Cancer Immunology, Immunotherapy, 62(1):149-59, 2013 Jan. doi: 10.1007/s00262-012-1326-1. PMID: 22865267
- Russ AJ, Xu K, Wentworth L, Alam S, Meyers JV, Macklin MD, Rakhmilevich AL, Rajamanickam V, Suresh M, Cho CS. Melanoma-induced suppression of tumor antigen-specific T cell expansion is comparable to suppression of global T cell expansion. Cellular Immunology, 271(1):104-9, 2013. doi: 10.1016/j.cellimm.2011.06.011. PMID: 21741629
- Russ Aj, Wentworth L, Xu K, Rakhmilevich A, Seroogy CM, Sondel PM, Suresh M, Cho CS. Suppression of T-cell expansion by melanoma is exerted on resting cells. Annals of Surgical Oncology, 18(13):3848-57, 2011 Dec. doi: 10.1245/s10434-011-1667-6. PMID: 21465311
- Cho CS, Chang Z, Elkahwaji J, Scheunemaa TL, Manthei ER, Colburn M, Knechtle SJ, Hamawy MM. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells. International Immunology, 15(11): 1369-78, 2003 Nov. PMID: 14565935
Key Publications
In the News
- Fawcett, Nicole. "Major Strides in Pancreatic Cancer Give 'Actual Reasons for Hope.'" MHealth Lab. November 5, 2018.
- Fawcett, Nicole. "Woman's Rare Diagnosis Prompts Sweeping Treatment to Target Cysts." Michigan Health News. January 13, 2019.
- Sendra, Jessica Webster. "HIPEC Treatment Targets Tough Cancers by ‘Bathing’ Tumors in Chemo." Michigan Health News. July 20, 2018.
Learn More
Dr. Cho discusses recent developments in the progress against pancreatic cancer.